(Q45139066)

9 December 2017

title

Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers (English)

1 reference

9 December 2017

1 reference

0 references

Antonio H Madrid

1

1 reference

9 December 2017

Irene Marín Marín

2

1 reference

9 December 2017

Carlos Escobar Cervantes

3

1 reference

9 December 2017

Enrique Bernal Morell

4

1 reference

9 December 2017

Jaime Escudero Estévez

5

1 reference

9 December 2017

Gerardo Moreno

6

1 reference

9 December 2017

Jorge Rondón Parajón

7

1 reference

9 December 2017

Jian Peng

8

1 reference

9 December 2017

Lilianna Limón

9

1 reference

9 December 2017

Sebastian Nannini

10

1 reference

9 December 2017

Concepción Moro

11

1 reference

9 December 2017

publication date

1 September 2004

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

9 December 2017

published in

1 reference

9 December 2017

volume

5

1 reference

9 December 2017

issue

3

1 reference

9 December 2017

page(s)

114-120

1 reference

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

A Case of a Short‐Coupled Variant of Torsades De Pointes with Electrical Storm

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Atrial fibrillation in hypertension: predictors and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Restoring sinus rhythm in atrial fibrillation: a Pyrrhic victory?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Blockade of atrial angiotensin II type 1 receptors: a novel antiarrhythmic strategy to prevent atrial fibrillation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Recent advances in drug therapy for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

Pharmacological Approaches in the Treatment of Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2004.027

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2004.027

1 reference

9 December 2017

1 reference